Will GLP-1 Compounds Become the Next Cash Only Medical Market?
It happened to cannabis. Is it about to happen to compounded GLP-1s?
In the United States, marijuana remains illegal at the federal level. That single designation, Schedule I, has done more than criminalize a plant. It has created an entire medical economy that exists in cash. Banks do not touch it. Credit card processors stay away. Stripe, Square, Visa, Mastercard, they all steer clear. Why? Because serving the cannabis industry runs them into trouble with federal regulation, even in states where it has been legal for years.
Keep reading with a 7-day free trial
Subscribe to On The Pen to keep reading this post and get 7 days of free access to the full post archives.